ClinicalTrials.gov
public full text
Public Domain
Description of Clinical Anatomical Features and Long Term Follow-up for Patients With ALK Rearrangements
Description of clinical and anatomical features and long-term follow-up for patients with ALK rearrangement and treated by crizotinib
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCL#160347
- Alprostadil in Peripheral Arterial Occlusive Disease (PAOD) Stage IV#903744
- QUILT-3.002: N-803 in Patients With Relapse/Refractory iNHL in Conjunction With Rituximab#471459
- Real-world Study of Local Therapy Changes During 1L Lorlatinib in Unresectable ALK+ NSCLC#852968
- Vonafexor ALPort Syndrome Efficacy & Safety TRIAl-1 (ALPESTRIA-1)#451528
Record · ID 1153138
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive